Name: Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv4-Ig)
SKU: FVTIG-164
Rating: 5 (1 reviews)

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-gp40 scFv is fused to the CH1 domain of a heavy chain and another anti-TFRC scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.

Datasheet INQUIRY

Specifications

Targets

gp40 & TFRC

Type

scFv4-Ig

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Colon cancer; Ovarian cancer

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

gp40

Alternative Names

gp40; glycoprotein 40; adenocarcinoma-associated antigen

Target 2

TFRC

Gene ID

7037

UniProt ID

P02786

Alternative Names

TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv4-Ig) (FVTIG-164). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-164)

Specifications

Targets

Customer Reviews and Q&As